The epidemiology of HIV-associated tuberculosis in rural Cambodia

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 1008-1013

  Cain, Kevin P ^a   Kanara, N ^a   Laserson, K F ^a   Vannarith, C ^b   Sameourn, K ^b   Samnang, K ^b   Qualls, M L ^a   Wells, C D ^a   Varma, J K ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Provincial AIDS Office   (Cambodia)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Cambodia; Epidemiology; HIV; Mortality; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CAMBODIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SPUTUM SMEAR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CAMBODIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; RURAL POPULATION; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 34548767132     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. Interim policy on collaborative TB-HIV activities. WHO/HTM/TB/2004.330. Geneva, Switzerland: WHO, 2004.
2. World Health Organization. WHO report 2005. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2005.349. Geneva, Switzerland: WHO, 2005.
3. Mukadi Y D, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001; 15: 143-152.
4. Centers for Disease Control and Prevention. Spotlight on syndemics. Atlanta, GA, USA: CDC, 2007. http://www.cdc.gov/syndemics/overview.htm Accessed June 2007.
5. Freudenberg N, Fahs M, Galea S, Greenberg A. The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic. Am J Public Health 2006; 96: 424-434.
6. Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q 2003; 17: 423-441.
7. Joint United Nations Program on HIV/AIDS. AIDS epidemic update: December 2005. Geneva, Switzerland: UNAIDS, 2005.
8. Centers for Disease Control and Prevention. Screening HIV-infected persons for tuberculosis - Cambodia, January 2004-February 2005. MMWR 2005; 54: 1177-1180.
9. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. AIDS 2006; 43: 42-46.
10. Quy H, Nhien D, Lan N, Borgdorff M, Broekmans J. Steep increase in HIV prevalence among tuberculosis patients in Ho Chi Minh City. AIDS 2002; 16: 931-932.
11. Quy H, Cobelens F, Lan N, Buu T, Lambregts C, Borgdorff M. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 45-51.
12. Ministry of Health: National Center for HIV/AIDS, Dermatology, and STD. Report on HIV sentinel surveillance in Cambodia 2002. Phnom Penh, Cambodia: MOH, 2002. http://www.nchads.org/Doc/Publication/HSS/Final%20HSS%202002.pdf Accessed 19 February 2006.
13. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003. http://www.who.int/tb/publications/cds_tb_2003_313/en/index.html Accessed June 2007.
14. Breiman L, Freidman J, Olshen R, Stone C. Classification and regression trees. New York, NY, USA: Wadsworth, 1984.
15. Hargreaves N J, Kadzakumanja O, Whitty C J, Salaniponi F M, Harries A D, Squire S B. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 2001; 5: 847-854.
16. Harries A D, Hargreaves N J, Gausi F, Kwanjana J H, Salaniponi F M. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5: 1000-1005.
17. Kang'ombe C T, Harries A D, Ito K, et al. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis 2004; 8: 829-856.
18. Siddiqi K, Lambert M L, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003; 3: 288-296.
19. Shah N, Schneider E, Nelson L, Laserson K, Wells C. Risk factors for smear-negative pulmonary tuberculosis among HIV-infected patients in the United States, 1993-2003. San Diego, CA, USA: American Thoracic Society International Conference, 2006.
20. Smith R L, Yew K, Berkowitz K A, Aranda C P. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest 1994; 106: 684-686.
21. World Health Organization. TB-HIV research priorities in resource-limited settings: report of an expert consultation. Geneva, Switzerland: WHO, 2005.